The shares of Indoco Remedies Ltd. surged over 12% at intraday trade on Wednesday, November 18 snapping a two-day losing streak for the company, marking the fourth biggest single day gain this year. The stock is also bucking the trend in an otherwise weak market.
The company’s shares had been trading in the red on both Monday and Tuesday, after it had achieved seven straight days of gains prior to the two-day drop. November has also been the second-best month for the stock this year so far, with the stock having risen more than 20% as per time of writing.
As a result of these gains seen in November, shares of Indoco Remedies have turned positive on a year-to-date basis, now trading 9.2% higher for the year.

Shareholding Pattern
As per the company’s shareholding pattern, 58.92% stake was owned by the company’s promoter and promoter groups, while the rest was held by public shareholders.
How did the Indoco Remedies fare in the second quarter
Indoco Remedies reported a net profit of ₹19.5 crore in the second quarter, compared with a loss of ₹9.2 crore in the year-ago period. Revenue grew 7.4% to ₹507 crore from ₹472 crore.
Its Earnings Before Interest, Taxes, Depreciation, and Amortisation (EBITDA) increased 10% to ₹33 crore from ₹30.2 crore, while the EBITDA margin improved to 6.5% from 6.4% a year earlier.
Also Read: Drugmaker stock surges 156% in a single session after data on cancer vaccine
Shares of Indoco Remedies are currently trading 8.6% higher on Wednesday at ₹243.7.
